Company Lexington BioSciences Inc Canadian Securities Exchange
Equities
CA5290201097
Medical Equipment, Supplies & Distribution
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Donald McInnes
CEO | Chief Executive Officer | 60 | 20-04-15 |
Bryan Disher
DFI | Director of Finance/CFO | 66 | 16-12-20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bryan Disher
DFI | Director of Finance/CFO | 66 | 16-12-20 |
Tamara Manuel
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 23,669,560 | 0 | 0 | 13.79 % |
Stock B | 1 | 3,786,840 | 3,785,340 ( 99.96 %) | 0 |
Company contact information
Lexington Biosciences, Inc.
1055 West Hastings Street Suite 1900
V6E 2E9, Vancouver
+
Sector
1st Jan change | Capi. | |
---|---|---|
-2.34% | 187B | |
+0.92% | 110B | |
-1.77% | 69.54B | |
+14.21% | 46.37B | |
-6.06% | 46.05B | |
+8.62% | 42.54B | |
+19.03% | 30.72B | |
+18.74% | 25.62B | |
-7.25% | 23.32B |